NCT03094403View on ClinicalTrials.gov

To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

April 1, 2017

Conditions
Rosacea
Interventions
DRUG

Azelaic Acid 15% topical gel

Gel

DRUG

Finacea® (azelaic acid) Gel, 15%

Gel

DRUG

Placebo

Gel

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT03094403 - To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel | Biotech Hunter | Biotech Hunter